Novel CRISPRgenee method combines gene silencing and cutting mechanisms to improve understanding of cellular control processes ...

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

Key growth drivers in the genome editing market include rising cancer/genetic disorder cases, increased investments, and supportive policies. North America leads in R&D, while Asia Pacific shows rapid ...

Cheyenne locals Georgia and Dave Rowswell, the owners of Open Door Arts (formerly Blue Door Arts), leave next week for an ...

The commercial success of existing lipid-lowering medications highlights the enormous market potential for effective ...

While biotech hubs like Boston, San Francisco, San Diego and Raleigh-Durham, North Carolina, are home to thousands of ...

Crispr Therapeutics is synonymous with Cathie Wood and now ranks at number 10 across ARK’s combined portfolio, worth an eye-catching $428.7 million, with a portfolio weighting of 3.29%. Her consistent ...

ABSTRACT: With an estimated 20.5 million deaths from cardiovascular diseases (CVDs) in 2021, around 80% of these deaths will occur in low- and middle-income countries, making CVDs the leading cause of ...

CRISPR: Is The Selloff Really Over? I guess that's what biotech investors should be familiar with, as the stock of CRISPR Therapeutics AG (CRSP) has truly undergone a roller coaster ride all year, ...